- Home
- EXK vs SPRY Comparison
EXK vs SPRY Comparison
Compare EXK & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXK
- SPRY
- Stock Information
- Founded
- EXK 1981
- SPRY 2015
- Country
- EXK Canada
- SPRY United States
- Employees
- EXK N/A
- SPRY N/A
- Industry
- EXK Precious Metals
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- EXK Basic Materials
- SPRY Health Care
- Exchange
- EXK Nasdaq
- SPRY Nasdaq
- Market Cap
- EXK 1.3B
- SPRY 1.4B
- IPO Year
- EXK N/A
- SPRY N/A
- Fundamental
- Price
- EXK $3.71
- SPRY $11.18
- Analyst Decision
- EXK Strong Buy
- SPRY Strong Buy
- Analyst Count
- EXK 4
- SPRY 4
- Target Price
- EXK $6.83
- SPRY $24.00
- AVG Volume (30 Days)
- EXK 6.0M
- SPRY 1.1M
- Earning Date
- EXK 11-05-2024
- SPRY 11-13-2024
- Dividend Yield
- EXK N/A
- SPRY N/A
- EPS Growth
- EXK N/A
- SPRY N/A
- EPS
- EXK N/A
- SPRY N/A
- Revenue
- EXK $225,927,000.00
- SPRY $2,568,000.00
- Revenue This Year
- EXK $10.36
- SPRY $95,526.66
- Revenue Next Year
- EXK $99.52
- SPRY $275.98
- P/E Ratio
- EXK N/A
- SPRY N/A
- Revenue Growth
- EXK N/A
- SPRY 8460.00
- 52 Week Low
- EXK $1.42
- SPRY $5.10
- 52 Week High
- EXK $5.67
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- EXK 35.85
- SPRY 32.88
- Support Level
- EXK $3.61
- SPRY $10.63
- Resistance Level
- EXK $4.04
- SPRY $14.50
- Average True Range (ATR)
- EXK 0.21
- SPRY 0.82
- MACD
- EXK -0.05
- SPRY -0.20
- Stochastic Oscillator
- EXK 10.18
- SPRY 14.26
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The company has three producing silver-gold mines in Mexico: the Guanacevi Mine in Durango, the Bolanitos Mine in Guanajuato and the El Compas Mine in Zacatecas. It also has three exploration projects in northern Chile: Aida project, Paloma project and the Cerro Marquez project.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.